Synonyms- |
Introduction- |
Target |
Mechanism CD30 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date19 Aug 2011 |
Target |
Mechanism CD30 inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CD30 inhibitors |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Jan 2025 |
Sponsor / Collaborator |
Start Date01 Mar 2024 |
Sponsor / Collaborator |
Start Date01 Jan 2024 |
Sponsor / Collaborator |